Trials / Completed
CompletedNCT00548860
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
A Multi-center, Randomized Controlled Study to Investigate the Safety and Tolerability of IV Ferric Carboxymaltose (FCM) vs Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,018 (actual)
- Sponsor
- American Regent, Inc. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The Objective of this study is to study the safety of FCM in patients with anemia caused by Heavy Uterine Bleeding and the Post Partum state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric Carboxymaltose | |
| DRUG | Standard Medical Care (SMC) |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-03-01
- Completion
- 2009-07-01
- First posted
- 2007-10-24
- Last updated
- 2018-02-20
- Results posted
- 2015-05-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00548860. Inclusion in this directory is not an endorsement.